Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Metadata
Title
HIV Sexual Risk Reduction Interventions With Heterosexual Men: The Forgotten Group
Authors
Theresa M. Exner
P. Sandor Gardos
David W. Seal
Anke A. Ehrhardt
Publication date
01-12-1999
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
AIDS and Behavior / Issue 4/1999
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1023/A:1025493503255

Other articles of this Issue 4/1999

AIDS and Behavior 4/1999 Go to the issue

OriginalPaper

Predictors of Long-Term Maintenance of Safer Sex and Lapse/Relapse: A Nine-Year Follow-up of the Chicago CCS/MACS Cohort

OriginalPaper

Behaviors That Facilite Sexual Transmission of HIV and STDs in a Rural Community

OriginalPaper

Levels of Emotional Distress Among Parents Living with AIDS and their Adolescent Children

OriginalPaper

Evaluation of an HIV Prevention Intervention for Men Who Have Sex with Men at Cruising Areas in the Netherlands

OriginalPaper

HIV Risk Behavior Patterns Among Young Thai Men

OriginalPaper

Other-Sensitive Motivation for Safer Sex Among Gay Men: Expanding Paradigms for HIV Prevention
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits